Exabis Library
Welcome to the e-CCO Library!
P743 Time trends of Crohn’s disease in Catalonia from 2011 to 2017. Increasing use of biologics correlates with a reduced need for surgery. A population-based study in Catalonia
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P743: Bone mineral disease is insufficiently evaluated in patients with inflammatory bowel disease at risk of metabolic bone disease: results from a Danish population-based inception cohort study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P743: Relative association of bowel urgency improvement versus remission of stool frequency and rectal bleeding with Patient Global Rating of Severity or Change scores in moderately-to-severely active Ulcerative Colitis: An analysis from the LUCENT-1 and LUCENT-2 Phase 3 trials
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P743: Ustekinumab use in Crohn´s Disease: Does short-term effectiveness correlate to induction regimen?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P743: What information is available on the internet and social media for faecal microbiota transplantation?
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P744 Epidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): Results from the nationwide EpidemIBD study of GETECCU
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P744: A significant decline in surgical resections during childhood with increased prevalence of anti-TNF therapy in patients with paediatric inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P744: Risk factors for faecal incontinence in patients with Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P744: Safety of live vaccines in children exposed to biological agents for inflammatory bowel disease (IBD) in utero or during breastfeeding
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P744: Therapeutic gain of continued, long-term infliximab therapy in Crohn’s disease patients with response but non-remission after one year of infliximab therapy
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P745 Perianal disease in Crohn’s disease is associated with higher rate of hospitalisation and mortality despite a higher utilisation of biologics: Report from the epiIIRN cohort
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P745: Impact of migration on IBD incidence in 8 European populations: results from Epicom 2010 inception cohort study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P745: Incidence of indeterminate colitis in the EPIMAD registry decreases over the period 1988–2014
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P745: Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohort
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P745: Switching between anti-TNF originator and biosimilar in patients with inflammatory bowel disease: Can it be recommended? A systematic review
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P746 Prevalence, features and outcomes of splachnic vein thrombosis in inflammatory bowel disease. A nationwide, retrospective study from the ENEIDA registry
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P746: Anthropometric measures in adolescents with inflammatory bowel disease: A population-based study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P746: Clinical characteristic of Crohn's disease patients in Polish population
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P746: Identification of Altered Microbial Genera at Baseline in Adalimumab Clinical Remitters and an Absence of Change in Total Microbial Composition Post Induction Treatment in the SERENE UC Study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P746: Living with ulcerative colitis in Germany: quantifying the socioeconomic impact of moderate to severe ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM